Antidilutive securities excluded from computation of diluted net loss per share (Details) - shares	12 Months Ended
Apr. 30, 2022	Apr. 30, 2021
Accounting Policies [Abstract]
Series A Preferred Stock, as converted		1,321,996
Series B Preferred Stock, as converted	822,230	1,640,563
Stock Options	3,694,142	2,197,475
Warrants	1,539,999	873,332
Restricted stock	1,083,675	687,500
Total	7,140,046	6,720,866

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration